We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36 | -2.70% | 49.00 | 48.50 | 49.79 | 49.61 | 48.58 | 49.50 | 2,973,970 | 21:00:10 |
From May 2019 to May 2024
By Nadya Masidlover
PARIS--French pharmaceutical company Sanofi SA (SNY) and Regeneron Pharmaceuticals Inc. (REGN) said they will seek U.S. regulatory approval for a new rheumatoid arthritis drug later this year.
The two companies said Thursday that the results from phase 3 studies of Sarilumab were positive in treating the symptoms of rheumatoid arthritis.
"Sarilumab is the first fully-human monoclonal antibody directed against the IL-6 receptor (IL-6R). Sarilumab binds with high affinity to the IL-6 receptor," the companies said.
They said that a request for U.S. regulatory approval will be put forward in the fourth quarter of 2015.
-Write to Nadya Masidlover at nadya.masidlover@wsj.com
Access Investor Kit for Sanofi
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=FR0000120578
Access Investor Kit for Regeneron Pharmaceuticals, Inc.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US75886F1075
Access Investor Kit for Sanofi
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US80105N1054
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
